中性粒细胞与淋巴细胞比值与肌少症关联的系统综述与荟萃分析
该系统综述与荟萃分析纳入39项观察性研究共17844名成人,发现肌少症患者的中性粒细胞与淋巴细胞比值(NLR)显著高于非肌少症者(SMD 0.22,95%CI 0.18-0.27,P<.001),高NLR与肌少症风险增加相关(OR 1.79,95%CI 1.49-2.14,P<.001)。在肿瘤人群中,NLR≥3.0可能有助于识别需进一步评估肌少症风险的个体,但结论需多中心前瞻性研究验证。
要点
- 肌少症患者NLR显著高于非肌少症者,高NLR与肌少症风险增加相关。
- 在肿瘤人群中,NLR≥3.0可能作为识别肌少症风险评估的标记。
- 该关联需设计良好的多中心前瞻性研究进一步验证。
核心结论
- NLR与肌少症存在显著关联,肌少症患者NLR更高,高NLR与肌少症风险增加相关。
- 在肿瘤人群中,NLR≥3.0可能有助于识别需进一步评估肌少症风险的个体。
- 上述发现需通过设计良好的多中心前瞻性研究验证。
研究设计与样本
- 系统综述与荟萃分析,纳入39项观察性研究,共17844名成人参与者。
- 检索Web of Science、PubMed、Ovid MEDLINE和Ovid Embase,从建库至2025年3月。
- 根据异质性采用固定效应或随机效应模型,并行亚组分析、敏感性分析和发表偏倚检验。
主要发现
- 肌少症患者NLR显著高于非肌少症者(SMD 0.22,95%CI 0.18-0.27,P<.001)。
- 高NLR与肌少症风险增加相关(OR 1.79,95%CI 1.49-2.14,P<.001)。
- 亚组和敏感性分析一致支持该关联;比较NLR水平的研究存在发表偏倚,但剪补法显示效应量稳健。
- 评估高与低NLR组间肌少症风险的分析未发现显著发表偏倚。
关键数值与推荐
- 在肿瘤人群中,NLR≥3.0可能作为识别需进一步评估肌少症风险个体的标记。
临床怎么用
- 在肿瘤人群中可考虑将NLR≥3.0作为提示需进一步评估肌少症风险的炎症标记。
- NLR可作为肌少症风险评估的辅助炎症指标,但需结合临床综合判断。
局限性
- 比较NLR水平的研究中检测到发表偏倚。
- 结论需通过设计良好的多中心前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To clarify the association between the neutrophil-to-lymphocyte ratio (NLR), a marker of systemic inflammation, and sarcopenia by systematically reviewing and meta-analyzing existing evidence. DESIGN: Systematic review and meta-analysis. SETTING AND PARTICIPANTS: This review included 39 observational studies, comprising a total of 17,844 adult participants. METHODS: A comprehensive literature search was conducted using Web of Science, PubMed, Ovid MEDLINE, and Ovid Embase from inception through March 2025. Eligible studies were evaluated for quality, and either fixed-effects or random-effects models were applied depending on heterogeneity. Forest plots were constructed to assess the association between NLR and sarcopenia. Subgroup analyses, sensitivity analyses, and tests for publication bias were also performed. RESULTS: Meta-analysis revealed that individuals with sarcopenia exhibited significantly elevated NLR levels compared with those without sarcopenia (standardized mean difference, 0.22; 95% CI, 0.18-0.27; P < .001). A high NLR was also associated with an increased risk of sarcopenia (odds ratio, 1.79; 95% CI, 1.49-2.14; P < .001). Subgroup and sensitivity analyses consistently supported this association. Although publication bias was detected in studies comparing NLR levels, the trim-and-fill method indicated that the effect size remained robust. No significant publication bias was found in analyses evaluating the risk of sarcopenia between high and low NLR groups. CONCLUSIONS AND IMPLICATIONS: These results suggest a significant association between NLR and sarcopenia. Adults with sarcopenia tend to exhibit higher NLR values, and elevated NLR is associated with increased sarcopenia risk. In cancer populations, an NLR ≥3.0 may serve as a valuable marker for identifying individuals who need further assessment for sarcopenia risk. However, these findings require validation through well-designed, multicenter prospective studies.
引用
- Wang J, Wang X, Li X, et al. Association Between Neutrophil-to-Lymphocyte Ratio and Sarcopenia: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2025. PMID: 41205998. doi:10.1016/j.jamda.2025.105977
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。